Transport of drugs from the nasal cavity to the central nervous system

European Journal of Pharmaceutical Sciences

Volumn 11, Issue 1, 2000, Pages 1-18

  Illum, Lisbeth ^a  

^a Albert Einstein Centre   (United Kingdom)

Author keywords

CNS; Drug transport; Nasal cavity

Indexed keywords

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; INTRANASAL DRUG ADMINISTRATION; NOSE CAVITY; OLFACTORY BULB; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PSEUDOPODIUM; REVIEW; TIGHT JUNCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; HUMANS; MENINGES; NASAL CAVITY; OLFACTORY MUCOSA; PHARMACOKINETICS;

EID: 0034095651     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00087-7     Document Type: Review

References (90)

1. Allison R.R., Stach P.E. Intrathecal drug therapy. Drug Intell. Clin. Pharm. 12:1978;347-359.
2. Anand Kumar T.C., David G.F.X., Umberkoman B., Saini K.D. Uptake of radioactivity by body fluids and tissues in rhesus monkeys after intravenous injection or intranasal spray of tritium-labelled estradiol and progesterone. Curr. Sci. 43:1974;435-439.
3. Anand Kumar T.C., David G.F.X., Kumar K., Umberkoman B., Krishnamoorthy M.S. A new approach to fertility regulation by interfering with neuroendocrine pathways. Anand Kumar T.C. Proceedings of International Symposium on Neuroendocrine Regulation and Fertility. 1976;314-322 Karger, Basel.
4. Anand Kumar T.C., David G.F.X., Puri V. Nasal spray contraceptive. Talwar G.P. Recent Advances in Reproduction and Regulation of Fertility. 1979;Elsevier, North Holland.
5. Anand Kumar T.C., David G.F.X., Sankaranarayanan A., Puri V., Sundaram R.R. Pharmacokinetics of progesterone after its administration to ovariectomised rhesus monkeys by injection, infusion, or nasal spraying. Proc. Natl. Acad. Sci. 79:1982;4185-4189.
6. Baker H., Spencer R.F. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp. Brain. Res. 63:1986;461-473.
7. Balda M.S., Matter K. Tight junctions. J. Cell Sci. 111:1998;541-547.
8. Balin B.J., Broadwell R.D., Salcman M., el-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat and squirrel monkey. J. Comp. Neurol. 8:1986;260-280.
9. Bodian D., Howe H.A. An experimental study of the role of the neurones in the dissemination of poliomyelitis virus in the nervous system. Brain. 63:1940;135-162.
10. Broadwell R.D., Balin B.J. Endocytic and exocytic pathways of the neuronal secretory process and transsynaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo. J. Comp. Neurol. 242:1985;632-650.
11. Bromley L., Hayward A. Cocaine absorption from the nasal mucosa. Anaesthesia. 43:1988;356-358.
12. Chen X.-Q., Fawcett J.R., Rahman Y.-E., Ala T.A., Frey W.H. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimer's Dis. 1:1998;35-44.
13. Char H., Kumar S., Patel S., Piemontese D., Iqbal K., Waseem Malick A., Salvador R.A., Behl C.R. Nasal delivery of [14C]dextromethorphan hydrochloride in rats: levels in plasma and brain. J. Pharm. Sci. 81:1992;750-752.
14. Chou K.-J., Donovan M.D. Distribution of antihistamines into the CSF following intranasal delivery. Biopharm. Drug Dispos. 18:1997;335-346.
15. Chou K.-J., Donovan M.D. The distribution of local anesthetics into the CSF following intranasal administration. Int. J. Pharm. 168:1998;137-145.
16. Chou K.-J., Donovan M.D. Lidocaine distribution into the CNS following nasal and arterial delivery: a comparison of local sampling and microdialysis techniques. Int. J. Pharm. 171:1998;53-61.
17. Chow H.-H.S., Chen Z., Natsuura G.T. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J. Pharm. Sci. 88:1999;754-758.
18. Citi S. Protein kinase inhibitors prevent junctional disassociation induced by low extracellular calcium in MDCK epithelial cells. J. Cell. Biol. 117:1992;169-178.
19. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryngol. 70:1970;58-61.
20. David G.F.X., Puri C.P., Anand Kumar T.C. Bioavailability of progesterone enhanced by intranasal spraying. Experientia. 37:1981;533-534.
21. Davson H., Welch K., Segal M.B. Secretion of cerebrospinal fluid. The Physiology and Pathophysiology of the Cerebrospinal Fluid. 1987;201 Churchill Livingstone, London.
22. De Lorenzo A.J.D. The olfactory neuron and the blood-brain barrier. Wolstenholme G.E.W., Knight J. Taste and Smell in Vertebras. 1970;151 J.A. Churchill, London.
23. De Souza Silva M.A., Mattern C., Hacker R., Nogueira P.J., Huston J.P., Schwarting R.K. Intranasal administration of the dopaminenergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. J. Neurochem. 68:1997;233-239.
24. Derad I., Willeke K., Pietrowsky R., Born J., Fehm H.L. Intranasal angiotensin II directly influences central nervous regulation of blood pressure. Am. J. Hypertens. 11:1998;971-977.
25. Einer-Jensen N. Preferential distribution to the brain of diazepam, but not cocaine, after nasal application in the rat. Eur. J. Pharm. Sci. 6:1998;S11.
26. Engstrom H., Blom E.K., Hansson A., Hansson P. The olfactory and respiratory epithelium in Rhesus and squirrel monkeys studied with freeze fracture techniques. Acta Otolaryngol. 108:1989;259-267.
27. Evans J., Hastings L. Accumulation of Cd(II) in the CNS depending on the route of administration: intraperitoneal, intratracheal or intranasal. Fundam. Appl. Toxicol. 19:1992;275-278.
28. Faber H.K. The early lesions of poliomyelitis after intranasal inoculation. J. Pediatr. 13:1938;10-37.
29. Faber W.M. The nasal mucosa and the subarachnoid space. Am. J. Anat. 62:1937;121-148.
30. Faber H.K., Gebhardt L.D. Localisations of the virus of the poliomyelitis in the central nervous system during the pre-paralytic period, after intranasal inoculation. J. Exp. Med. 57:1933;933-954.
31. Fairbrother R.W., Hurst E.W. The pathogenesis of, and propagation of the virus in, experimental poliomyelitis. J. Path. Bact. 33:1930;17-45.
32. Flexner S. The mode of infection of epidemic poliomyelitis. J. Am. Med. Assoc. 59:1912;1371.
33. 125I-NGF to the brain via the olfactory route. Drug Del. 4:1997;87-92.
34. 125I-labeled nerve growth factor to the brain via the olfactory route. Iqbal K., Mortimer J.A., Winblad B., Wisniewski H.M. Research Advances in Alzheimer's Disease and Related Disorders. 1995;329-335 John Wiley, New York.
35. Gianutsos G., Morrow G.R., Morris J.B. Accumulation of manganese in rat brain following intranasal administration. Fundam. Appl. Toxicol. 37:1997;102-105.
36. Gizurarson S., Thorvaldsson T., Sigurdsson P., Gunnarsson E. Selective delivery of insulin into the brain: intraolfactory absorption. Int. J. Pharm. 140:1996;77-83.
37. Gopinath P.G., Gopinath G., Kumar T.C.A. Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intranasal route of drug delivery. Curr. Ther. Res. 23:1978;596-607.
38. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky S., Rubinraut S., Fridkin M., Brenneman A.E. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA. 93:1996;427-432.
39. Harkema J.R. Comparative aspects of nasal airway anatomy: relevance to inhalation toxicology. Toxicol. Pathol. 19:1991;321-336.
40. Hastings L., Evans J.E. Olfactory primary neurons as a route of entry for toxic agents into the CNS. Neurotoxicology. 12:1991;707-714.
41. Hilger P.A. Applied anatomy and physiology of the nose. Adams G.L., Boies L., Hilger P.A. Fundamentals of Otolaryngology. A Textbook of Ear, Nose and Throat Diseases. 1989;177-195 W.B. Saunders, Philadelphia.
42. Hussain A., Foster T., Hirai S., Kashihara T., Batenhorst R., Jones M. Nasal absorption of propranolol in humans. J. Pharm. Sci. 69:1980;1240-1242.
43. Hussain A.A., Hirai S., Bawarshi R. Nasal absorption of natural contraceptive steroids in rats - progesterone absorption. J. Pharm. Sci. 70:1981;466-467.
44. Hussain M.A., Rakestraw D., Rowe S., Aungst B.J. Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery. J. Pharm. Sci. 79:1990;771-772.
45. Illum L. Animal models for nasal delivery. J. Drug Target. 3:1996;427-442.
46. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189.
47. Itaya S.K. Anterograde transsynaptic transport of WGA-HRP in rat olfactory pathways. Brain Res. 409:1987;205-214.
48. Jackson R.T., Tigges J., Arnold W. Subarachnoid space of the CNS, nasal mucosa and lymphatic system. Arch. Otolaryngol. 105:1979;180-184.
49. Javaid J.I., Davis J.M. Cocaine disposition in discrete regions of rat brain. Biopharm. Drug Dispos. 14:1993;357-364.
50. Kao H.D. Enhancement of Delivery of L-dopa by the Administration of its Prodrugs via the Nasal Route. 1995;The University of Kentucky, USA. Ph.D. Thesis.
51. Kern W., Born J., Schreiber H., Fehm H.L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes. 48:1999;557-563.
52. Kern W., Schiefer B., Schwarzenburg J., Stange E.F., Born J., Fehm H.L. Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans. Neuroendocrinology. 65:1997;291-298.
53. Krieger J., Breer H. Olfactory reception in invertebrates. Science. 286:1999;720-723.
54. Kristensson K., Olsson Y. Uptake of exogenous proteins in mouse olfactory cells. Acta Neuropathol. 19:1971;145-154.
55. Kucheryanu V.G., Kryzhanovsky G.N., Kudrin V.S., Yurasov V.V., Zhigaltsev I.V., Bocharov E.V. Intranasal fibroblast growth factors delivery into the brain exerts antiparkinsonian effect in mice. Proceedings International Symposium on Controlled Release of Bioactive Materials. Vol. 26:1999;643-644.
56. Kumbale R., Frey W.H., Wilson S., Rahman Y.E. GM1 delivery to the CSF via the olfactory pathway. Drug Del. 6:1999;23-30.
57. Landsteiner K., Levaditi C. Etude experimentale de la Poliomyelite aigue (Maladie Heine Medin). Ann. Inst. Pasteur. 24:1910;833-878.
58. Mackay-Sim A., Kittel P.W. On the life span of olfactory receptor neurones. Eur. J. Neurosci. 3:1991;209-215.
59. Madara J.L., Dharmsathaphorn K. Occluding junction structure function relationship in a cultured epithelial monolayer. J. Cell. Biol. 101:1985;2124-2133.
60. Madara J.L., Barnberg D., Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells; further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell. Biol. 102:1986;2125-2136.
61. Mathison S., Nagilla R., Kompella U.B. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J. Drug Del. 5:1998;415-441.
62. Moran D.T., Rowley J.C., Jafek B.W. The fine structure of olfactory mucosa in man. J. Neurocytol. 11:1982;721-746.
63. Mygind N. Nasal Allergy. 1978;Blackwell Science, Oxford.
64. Okuyama S. The first attempt at radioisotopic evaluation of the integrity of the nose-brain barrier. Life Sci. 60:1997;1881-1884.
65. Pardridge W.M. Peptide Drug Delivery to the Brain. 1991;99-122 Raven Press, New York.
66. Perl D.P., Good P.F. Uptake of aluminium into central nervous system along nasal olfactory pathways. Lancet. 1987;1028. May 2.
67. Pietrowsky R., Struben C., Molle M., Fehm H.L., Born J. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol. Psychiatry. 39:1996;332-340.
68. Pietrowsky R., Thieman A., Kern W., Fehm H.L., Born J. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology. 21:1996;559-572.
69. Rao A.J., Moudal N.R., Li C.H. β-Endorphin: intranasal administration increases the serum prolactin level in monkey. Int. J. Pept. Protein Res. 28:1986;546-548.
70. Reiss C.S., Plakhov I.V., Komatsu T. Viral replication in the olfactory receptor neurons and entry into the olfactory bulb and brain. Ann. NY Acad. Sci. 30:1998;751-761.
71. Rieselbach R.E., Di Chiro D., Freireich E.J., Rall D.P. Subarachnoid distribution of drugs after lumbar injection. N. Engl. J. Med. 267:1962;1273-1278.
72. Sabin A.B., Olitsky P.K. Influence of pathway of infection on pathology of olfactory bulbs in experimental poliomyelitis. Proc. Soc. Exp. Biol. Med. 35:1936;300-301.
73. Sabin A.B., Olitsky P.K. The olfactory bulbs in experimental poliomyelitis. Their pathologic condition as an indicator of the portal entry of the virus. J. Am. Med. Assoc. 108:1937;21-24.
74. Sabin A.B., Olitsky P.K. Influence of host factors on neuroinvasiveness of vesicular stomatitis virus. I. Effect of age on the invasion of the brain by viruses instilled in the nose. J. Exp. Med. 66:1937;15-34.
75. Sabin A.B., Olitsky P.K. Fate of nasally instilled poliomyelitis virus in normal and convalescent monkeys with special reference to the problem of host to host transmission. J. Exp. Med. 68:1938;39-61.
76. Sakane T., Akizuki M., Yoshida M., Yamashita S., Nadai T., Hashida M., Sezaki H. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J. Pharm. Pharmacol. 43:1991;449-451.
77. Sakane T., Akizuki M., Yamashita S., Nadai T., Hashida M., Sezaki H. The transport of drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem. Pharm. Bull. 39:1991;2456-2458.
78. Sakane T., Akizuki M., Yamashita S., Sezaki H., Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug. J. Pharm. Pharmacol. 46:1994;378-379.
79. Sakane T., Akizuki M., Yamashita S., Sezaki H., Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J. Pharm. Pharmacol. 47:1995;379-381.
80. Seki T., Sato N., Hasegawa T., Kawaguchi T., Juni K. Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. Biol. Pharm. Bull. 17:1994;1135-1137.
81. Serby M.J., Chobor K.L. Science of Olfaction. 1992;Springer-Verlag, New York.
82. Shipley M.T. Transport of molecules from nose to brain: transneural anterograde and retrograde labelling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res. Bull. 15:1985;129-142.
83. Sigurdsson P., Thorvaldsson T., Gizurarson S. Olfactory absorption of insulin to the brain. Drug Del. 4:1997;195-200.
84. Silva M.A., Mattern C., Hacker R., Tomaz C., Huston J.P., Schwarting R.K. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment. Synapse. 27:1997;294-302.
85. Smolnik R., Molle M., Fehm H.L., Born J. Brain potentials and attention after acute and subchronic intranasal administration of ACTH 4-10 and desacetyl-alpha-MSH in humans. Neuroendocrinology. 70:1999;63-72.
86. Stevenson B.R., Anderson J.M., Bullivant S. The epithelial tight junction: structure, function and preliminary biochemical characterisation. Mol. Cell. Biochem. 83:1988;129-145.
87. Stewart W.B. Labelling of olfactory bulb glomeruli following horseradish peroxidase lavage of the nasal cavity. Brain Res. 347:1985;200-203.
88. Thorne R.G., Emory C.R., Ala T.A., Frey W.H. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 692:1995;278-282.
89. Tjalve H., Henriksson J., Tallkvist J., Larsson B.S., Lindquist N.G. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol. Toxicol. 79:1996;347-356.
90. Wang Y., Aun R., Tse F.L.S. Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat. Biopharm. Drug Dispos. 19:1998;571-575.